Eivind Berge

Senior consultant and professor in vascular medicine.

[Eivind Berge @eiberge]

BP-lowering treatment based on CV risk compared with SPB: The SPRINT Data Analysis Challenge (https://t.co/9c8JOhbYh3)

[Eivind Berge @eiberge]

Importance of independent DMCs. https://t.co/8kNYxINvtz

[Daniela Rohde @dannifromdublin]

Systolic blood pressure variability is associated with increased risk of ischaemic stroke #esoc16

[Shaun Treweek @shauntreweek]

Great description of a huge source of research waste - the research grants process, in this case EU grants: https://t.co/JB484cE7Ds

[European Stroke Org @ESOstroke]

Reserve today: ESO and Lancet Neurology Symposium: Increasing value and reducing waste in clinical stroke research https://t.co/3ymJsR4fPf

[Trial Forge @Trial_Forge]

Improving retention in trials using SMS: a embedded study led by York Trials Unit and supported by Trial Forge https://t.co/i59SmGAQiR

[Shaun Treweek @shauntreweek]

Cost of 260 studies with poor recruitment in 2011: almost $1 million. Lots of expense but little scientific benefit https://t.co/3dMitV1HnX

[Eivind Berge @eiberge]

@GABOmi_EU @PRECIOUS_trial Imporant trial underway.

[BRIC Brain Imaging @EdinUniBRIC]

RT @EdinUniBrainSci: Here's Peter Sandercock receiving Lifetime Achievement Award from @UKStrokeForum. Well done!

[Sanjay Sharma @SSharmacardio]

Black athletes may show ECG changes that could be mistaken for a heart attack!http://t.co/ubcQstbzd0

[Eivind Berge @eiberge]

Stroke in Patients With Aortic Stenosis: The Simvastatin and Ezetimibe in... - reviewed in @F1000 http://t.co/t8UDc2kSSn